跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 964 条关于
“Ipsen SA”
全部
964
临床试验
136
药物
272
机构
269
资讯
287
2个月前
Ipsen Acquires Memo Therapeutics in Deal Worth Up to €700 Million, Validating Antibody Discovery Platform
去年
Global Cerebral Palsy Clinical Trial Landscape Assessed in New 2024 Review
7个月前
Ipsen Partners with Origami Therapeutics on Protein Degrader Program for Rare Neurodegenerative Diseases
4天前
FDA Clears IND for IPN60330, First MAIT Cell Engager, Paving Way for Phase 1 in Solid Tumors
去年
Global Polycystic Kidney Disease Clinical Trials Landscape Mapped in Comprehensive 2025 Review
去年
Ipsen Advances Pipeline with Multiple Regulatory Wins and Strategic Partnerships in 2024
去年
Ipsen Restructures Executive Leadership with Three Key Appointments to Drive Growth in Oncology and Rare Disease
去年
Adaptimmune's TECELRA Marks First Engineered Cell Therapy Approval for Solid Tumors in Synovial Sarcoma
去年
Robust Pipeline of 220+ Drugs Advancing for Gastric Cancer Treatment, Led by Major Pharmaceutical Companies
9个月前
Ipsen Secures Global Rights to Novel LRRC15-Targeting ADC in $1.06 Billion Deal with Simcere Zaiming
第 1 页,共 29 页
上一页
下一页